(1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production.
暂无分享,去创建一个
Danielle E. Dettling | T. R. Johnson | Mostofa A Hena | Y. Smith | T. Krieger-Burke | B. Lefker | W. Harter | J. Li | D. Pocalyko | H. Welgus | Brian Samas | M. Stier | S. Maiti | Jennifer K Hoffman | C. Kostlan | D. Sliskovic | S. Ciotti | K. Lapham | Q. Ding | Yun Huang | H. Lei | Mathew Carroll | L. Hu | L. Mitchell | D. Du | W. Yue | S. Kesten | V. Fedij | N. Barvian | Radhika Yalamanchili | Brenda Stoller
[1] G. Allan,et al. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists. , 2007, Bioorganic & medicinal chemistry letters.
[2] J. Dalton,et al. Chemistry and structural biology of androgen receptor. , 2005, Chemical reviews.
[3] Duane D. Miller,et al. Structural basis for antagonism and resistance of bicalutamide in prostate cancer , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[4] T. Nyrönen,et al. Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain. , 2005, Journal of medicinal chemistry.
[5] Y. Fradet. Bicalutamide (Casodex®) in the treatment of prostate cancer , 2004, Expert review of anticancer therapy.
[6] T. Sugino,et al. Fatty Acid Synthase Is Expressed Mainly in Adult Hormone-sensitive Cells or Cells with High Lipid Metabolism and in Proliferating Fetal Cells1 , 2000 .
[7] S. Schaus,et al. Asymmetric ring opening of meso epoxides with TMSCN catalyzed by (pybox)lanthanide complexes. , 2000, Organic letters.
[8] F. Labrie,et al. Androgen receptor antagonists (antiandrogens): structure-activity relationships. , 2000, Current medicinal chemistry.
[9] L. Denis,et al. Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer , 1998, Clinical pharmacokinetics.
[10] G. Heinze,et al. Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial. , 1998, Archives of dermatology.
[11] J. Dubois,et al. Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. , 1997, Journal of pharmaceutical sciences.
[12] W. Bergfeld,et al. Treatment of androgenic disorders in women: acne, hirsutism, and alopecia. , 1990, Cleveland Clinic journal of medicine.
[13] G. Plewig,et al. Hamster ear model for sebaceous glands. , 1977, The Journal of investigative dermatology.
[14] J. C. Shaw. Acne: effect of hormones on pathogenesis and management. , 2002, American journal of clinical dermatology.